A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
Po HuYong SunChang-Ling LiRui JinQiang XieXue-Jun JiangLian-Pin WuJian-Jun JiangXin-Biao QiuYu CaoGuang JiHua WangZhu-Hua YaoBin LiYong XiaJian'an WangJun JiangPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)
In this multicenter, head-to-head, randomized trial, the new-generation LONGTY DCB was noninferior to the SeQuent Please DCB for the primary endpoint of target lesion late lumen loss at 9 months.